Tadeusz Robak
Department of Hematology
Medical University of Lodz
Copernicus Memorial Hospital
93-510 Lodz
Poland
Name/email consistency: high
- Novel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activity. Robak, E., Robak, T. Curr. Med. Chem. (2012)
- Rituximab for chronic lymphocytic leukemia. Robak, T. Expert. Opin. Biol. Ther (2012)
- Management of hairy cell leukemia variant. Robak, T. Leuk. Lymphoma (2011)
- New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies. Robak, T., Robak, E. BioDrugs (2011)
- New nucleoside analogs for patients with hematological malignancies. Robak, T. Expert. Opin. Investig. Drugs (2011)
- Novel and emerging drugs for acute myeloid leukemia: pharmacology and therapeutic activity. Robak, T., Szmigielska-Kapłon, A., Pluta, A., Grzybowska-Izydorczyk, O., Wolska, A., Czemerska, M., Wierzbowska, A. Curr. Med. Chem. (2011)
- Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment. Robak, T. Cancer Treat. Rev. (2011)
- Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia. Robak, T., Dmoszynska, A., Solal-Céligny, P., Warzocha, K., Loscertales, J., Catalano, J., Afanasiev, B.V., Larratt, L., Geisler, C.H., Montillo, M., Zyuzgin, I., Ganly, P.S., Dartigeas, C., Rosta, A., Maurer, J., Mendila, M., Saville, M.W., Valente, N., Wenger, M.K., Moiseev, S.I. J. Clin. Oncol. (2010)
- Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Robak, T., Lech-Maranda, E., Robak, P. Expert. Rev. Anticancer. Ther (2010)
- Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study). Robak, T., Jamroziak, K., Gora-Tybor, J., Stella-Holowiecka, B., Konopka, L., Ceglarek, B., Warzocha, K., Seferynska, I., Piszcz, J., Calbecka, M., Kostyra, A., Dwilewicz-Trojaczek, J., Dmoszyñska, A., Zawilska, K., Hellmann, A., Zdunczyk, A., Potoczek, S., Piotrowska, M., Lewandowski, K., Blonski, J.Z. J. Clin. Oncol. (2010)
- Novel drugs for chronic lymphoid leukemias: mechanism of action and therapeutic activity. Robak, T. Curr. Med. Chem. (2009)
- Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group. Robak, T., Blonski, J.Z., Wawrzyniak, E., Gora-Tybor, J., Palacz, A., Dmoszynska, A., Konopka, L., Warzocha, K., Jamroziak, K. Cancer (2009)
- Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases. Robak, T., Korycka, A., Lech-Maranda, E., Robak, P. Molecules (2009)
- GA-101, a third-generation, humanized and glyco-engineered anti-CD20 mAb for the treatment of B-cell lymphoid malignancies. Robak, T. Curr. Opin. Investig. Drugs (2009)
- Current and emerging therapies for acute myeloid leukemia. Robak, T., Wierzbowska, A. Clin. Ther (2009)
- Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus. Robak, E., Kierstan, M., Cebula, B., Krawczynska, A., Sysa-Jedrzejowska, A., Wierzbowska, A., Smolewski, P., Robak, T. Lupus (2009)
- TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies. Robak, T., Robak, P., Smolewski, P. Curr. Opin. Investig. Drugs (2009)
- Current and emerging treatments for chronic lymphocytic leukaemia. Robak, T., Jamroziak, K., Robak, P. Drugs (2009)
- Emerging drugs for rarer chronic lymphoid leukemias. Robak, T. Expert. Opin. Emerg. Drugs (2008)
- Novel monoclonal antibodies for the treatment of chronic lymphocytic leukemia. Robak, T. Curr. Cancer. Drug. Targets (2008)
- Alemtuzumab for B-cell chronic lymphocytic leukemia. Robak, T. Expert. Rev. Anticancer. Ther (2008)
- Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia. Robak, T., Smolewski, P., Cebula, B., Grzybowska-Izydorczyk, O., Błoński, J.Z. Eur. J. Haematol. (2007)
- Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial. Robak, T., Jamroziak, K., Gora-Tybor, J., Blonski, J.Z., Kasznicki, M., Dwilewicz-Trojaczek, J., Wiater, E., Zdunczyk, A., Dybowicz, J., Dmoszynska, A., Wojtaszko, M., Zdziarska, B., Calbecka, M., Kostyra, A., Hellmann, A., Lewandowski, K., Stella-Holowiecka, B., Sulek, K., Gawronski, K., Skotnicki, A.B., Nowak, W., Zawilska, K., Molendowicz-Portala, L., Kloczko, J., Sokolowski, J., Warzocha, K., Seferynska, I., Ceglarek, B., Konopka, L. Blood (2007)
- Recent progress in the management of chronic lymphocytic leukemia. Robak, T. Cancer Treat. Rev. (2007)
- Current treatment options in prolymphocytic leukemia. Robak, T., Robak, P. Med. Sci. Monit. (2007)
- Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders. Robak, T., Wierzbowska, A., Robak, E. Rev. Recent. Clin. Trials (2006)
- Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies. Robak, T., Korycka, A., Robak, E. Recent. Pat. Anticancer. Drug. Discov (2006)
- Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2). Robak, T., Blonski, J.Z., Gora-Tybor, J., Jamroziak, K., Dwilewicz-Trojaczek, J., Tomaszewska, A., Konopka, L., Ceglarek, B., Dmoszynska, A., Kowal, M., Kloczko, J., Stella-Holowiecka, B., Sulek, K., Calbecka, M., Zawilska, K., Kuliczkowski, K., Skotnicki, A.B., Warzocha, K., Kasznicki, M. Blood (2006)
- New agents in chronic lymphocytic leukemia. Robak, T. Curr. Treat. Options. Oncol (2006)
- Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Robak, T. Cancer Treat. Rev. (2006)
- Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma. Robak, T., Smolewski, P., Cebula, B., Szmigielska-Kaplon, A., Chojnowski, K., Blonski, J.Z. Cancer (2006)
- Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity. Robak, T., Lech-Maranda, E., Korycka, A., Robak, E. Curr. Med. Chem. (2006)
- Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications. Robak, T., Korycka, A., Kasznicki, M., Wrzesien-Kus, A., Smolewski, P. Curr. Cancer. Drug. Targets (2005)
- Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia. Robak, E., Góra-Tybor, J., Kordek, R., Wawrzyniak, E., Bartkowiak, J., Bednarek, A., Constantinou, M., Kałuzewski, B., Robak, T. Br. J. Dermatol. (2005)
- Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies. Robak, T. Drugs. Aging (2005)
